Senior Director, Global Medical Cardiovascular, Medical Product Lead
Core
Strategic leader responsible for developing and executing the worldwide medical strategy for Milvexian, a novel anticoagulant, focusing on atrial fibrillation and secondary stroke prevention indications.
Role type
Senior Director, Worldwide Medical Product Lead (Strategic IC)
Builds
Global medical strategies, scientific narratives, and evidence generation plans for Milvexian
Domain
Life Sciences / Cardiovascular Medicine / Thrombosis
Required skills
Advanced degree (MD/PharmD/PhD), 8+ years in pharma medical affairs/strategy, cardiovascular/thrombosis expertise, alliance partnership experience, global matrix leadership, evidence generation strategy, external expert engagement
Preferred skills
Factor XI/XIa science knowledge, late-stage development experience, co-commercialization environment navigation
Technologies
None stated
Responsibilities
Develop and execute worldwide medical affairs strategy for Milvexian; Lead cross-functional Asset/Indication Medical Strategy (AIMS) team; Define scientific narrative incorporating factor XIa mechanism; Manage Phase 3 LIBREXIA-AF and LIBREXIA-STROKE studies; Partner with alliance counterparts (Johnson & Johnson) for joint governance; Lead Integrated Evidence Plans (IEP) and global medical data generation strategies; Engage global external experts in thrombosis and stroke prevention; Shape target product profile and label strategy.
Seniority
Senior Director, strategic leadership with people management
